Users Discontinuing Weight-Loss Medications Gain Back Pounds at a Quadrupled Rate Compared to Those on Conventional Diets

A recent study reveals that patients who come off new slimming jabs like Wegovy and Mounjaro may regain lost weight at a significantly accelerated pace than those who end traditional lifestyle regimens.

Published data in a leading health publication demonstrates that while obese people frequently drop about a fifth of their body weight while undergoing treatment, the weight comes back at an average rate of nearly a kilo each month after stopping.

"People purchasing these treatments should be informed of the potential of rapid rebound weight gain when the medication concludes," warns researcher Dr. Susan Jebb.

That rate of regain means a reversion to original weight in about one and a half years.

Analyzing Treatments

The study, which examined dozens of trials involving over 9,000 of participants, contrasted the outcomes of the injectable medications with older methods.

Scientists emphasize that individuals who lose weight through lifestyle changes alone typically see a more gradual weight regain—approximately 0.1 kg a month—after stopping.

Understanding the Fast Regain

Doctors propose the mechanism of the drugs explains the heightened rebound.

GLP-1 drugs imitate a body's own chemical called glucagon-like peptide-1, which helps regulate hunger.

"Long-term administration of the hormone concentrations far above than the body's typical production could lead to the body to generate a reduced amount of its endogenous hormone, and may also reduce sensitivity to its effects," noted Dr. Adam Collins, a nutrition specialist.

"Discontinuation of this hormone supplement results in appetite is uncontrolled, making overeating a significant risk."

A Chronic Issue?

Medical guidelines advise the jabs for individuals with weight-linked health risks, alongside prescribed lifestyle changes.

A number of clinicians say that, considering the significant potential of relapse, the therapy is often long-term.

This opinion is echoed by drug manufacturers, who say that the findings "emphasize the persistent nature of excess weight," akin to managing diseases like high blood pressure.

User Experiences

People who have discontinued the jabs explain a sudden resurgence of hunger.

"It was like a switch activating and I was suddenly starving," recalled one woman.

This difficulty is worsened if patients have not developed lasting lifestyle or habit changes during therapy.

Widespread Adoption

Survey data suggest that a significant number of adults in the UK have used these injections in the last 12 months, with demand being substantial.

• Adoption is greater among women than men.
• The middle-aged demographic shows the highest level of interest.
• Many obtain the drugs through private prescriptions rather than the NHS.

Finally, researchers stress that while the jabs are potent tools for shedding pounds, they are not a magic cure and maintained weight loss likely depends on ongoing behavioural changes.